Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine
Open Access
- 22 August 2003
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 18 (4) , 401-408
- https://doi.org/10.1046/j.1365-2036.2003.01683.x
Abstract
Background: Tioguanine (TG) is an antimetabolite which may be regarded as an alternative to azathioprine (AZA)/mercaptopurine (MP) in patients with inflammatory bowel diseases. Aims : To evaluate th...Keywords
This publication has 40 references indexed in Scilit:
- The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblastsPublished by Elsevier ,2003
- 6-Thioguanine in azathioprine and 6-mercaptopurine intolerant patients with inflammatory bowel diseasePublished by Wiley ,2002
- Idiosyncratic adverse reactions to 6-mercaptopurine (6-MP) and azathioprine(AZA) can be averted by switching to thiioguanine(6-TG) in patients with IBDGastroenterology, 2001
- Idiosyncratic adverse reactions to 6-mercaptopurine (6-MP) and azathioprine(AZA) can be averted by switching to thiioguanine(6-TG) in patients with IBDGastroenterology, 2001
- 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.Gut, 1996
- Peliosis hepatis induced by 6-thioguanine administration.Gut, 1988
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980
- Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation.Gut, 1979
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958